Targacept Is Developing A Diversepipelineof Innovativennr Therapeuticsa C For Difficult To Treat Diseases And Disorders Of Thenervous System Nnr Therapeutics Selectively Modulatetheactivity Of Specific Neuronal Nicotinic Receptorsuniqueproteins That Regulatevital Biological Functions That Areimpaired In Various Diseasestates Targacept S Clinical Pipelineincludes Multiplephase2 Product Candidatesall Representing First In Class Opportunities Targacept Leverages Its Scientific Leadership And Diversepipelineto Attract Significant Collaborations With Global Pharmaceutical Companies For Moreinformationpleasevisit Www Targacept Com
No conferences found for this company.
| Company Name | Targacept Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
